Nevro Corp. - NYSE: NVRO
Nevro is a medical device company headquartered in Redwood City, CA.
We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain.
We started with a simple mission to help more patients suffering from chronic pain.
At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS).